Furthermore, the frequency of these cells in the intestinal LP is increased in human patients with UC but not Crohn's disease (14), and their regulatory activity is significantly reduced in inflamed UC tissue due to an increase in the proportion of IL-17-expressing LAP+ cells (14). Here, IL17A is linked to Crohn disease.